Effects of SRX246, a Vasopressin Receptor (V1a) Antagonist, on an Experimental Model of Phasic and Sustained Threat in Humans

SRX246 - Azevan

Tiffany Lago, M.D.;Michael Brownstein;Emily Beydler;Adrienne Manbeck;Alexis Beale;Neal Simon;Christian Grillon;Monique Ernst

Oct 17, 2019